Pacira Biosciences, Inc. (PCRX)
25.21
+0.20
(+0.80%)
USD |
NASDAQ |
Oct 02, 16:00
25.18
-0.03
(-0.12%)
After-Hours: 20:00
Pacira Biosciences Price : 25.21 for Oct. 2, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 02, 2026 | 25.04 | 25.66 | 24.66 | 25.21 | 469795.0 |
| Oct 01, 2026 | 25.05 | 25.38 | 24.92 | 25.01 | 510599.0 |
| Sep 30, 2026 | 25.59 | 25.77 | 24.90 | 25.05 | 628469.0 |
| Sep 29, 2026 | 25.30 | 25.67 | 25.13 | 25.65 | 643596.0 |
| Sep 28, 2026 | 25.15 | 25.76 | 24.79 | 25.39 | 483056.0 |
| Sep 25, 2026 | 25.50 | 25.66 | 25.00 | 25.12 | 444231.0 |
| Sep 24, 2026 | 24.58 | 25.60 | 24.50 | 25.56 | 725147.0 |
| Sep 23, 2026 | 25.00 | 25.20 | 24.51 | 24.63 | 450691.0 |
| Sep 22, 2026 | 24.36 | 24.96 | 24.20 | 24.70 | 380504.0 |
| Sep 21, 2026 | 24.79 | 24.98 | 23.98 | 24.11 | 375530.0 |
| Sep 18, 2026 | 24.36 | 24.72 | 24.20 | 24.69 | 680876.0 |
| Sep 17, 2026 | 25.11 | 25.20 | 24.45 | 24.48 | 393793.0 |
| Sep 16, 2026 | 24.06 | 24.91 | 24.06 | 24.91 | 759129.0 |
| Sep 15, 2026 | 24.63 | 24.94 | 23.65 | 24.08 | 824514.0 |
| Sep 14, 2026 | 25.71 | 25.99 | 24.65 | 24.68 | 418438.0 |
| Sep 11, 2026 | 25.43 | 25.57 | 25.18 | 25.36 | 538041.0 |
| Sep 10, 2026 | 25.92 | 26.00 | 25.10 | 25.16 | 733774.0 |
| Sep 09, 2026 | 25.62 | 25.88 | 25.13 | 25.88 | 571737.0 |
| Sep 08, 2026 | 25.98 | 26.41 | 25.68 | 25.87 | 386424.0 |
| Sep 04, 2026 | 26.38 | 26.65 | 26.31 | 26.35 | 481690.0 |
| Sep 03, 2026 | 26.74 | 26.84 | 26.32 | 26.60 | 598521.0 |
| Sep 02, 2026 | 26.52 | 26.91 | 26.24 | 26.58 | 610789.0 |
| Sep 01, 2026 | 26.01 | 26.50 | 25.98 | 26.47 | 729463.0 |
| Aug 31, 2026 | 25.75 | 26.07 | 25.46 | 25.90 | 380508.0 |
| Aug 28, 2026 | 25.74 | 26.04 | 25.56 | 25.76 | 483553.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Johnson & Johnson | 256.03 |
| Liquidia Corp. | 28.64 |
| ANI Pharmaceuticals, Inc. | 72.18 |
| Corcept Therapeutics, Inc. | 116.23 |
| Veru, Inc. | 2.51 |
Price Related Metrics
| PE Ratio | 72.63 |
| PS Ratio | 1.424 |
| Price to Book Value | 1.494 |
| Price to Free Cash Flow | 5.921 |
| Earnings Yield | 1.38% |
| Market Cap | 1.004B |
| Operating PE Ratio | 38.47 |
| Normalized PE Ratio | 51.74 |